Australia's Monash University have received a $2.97 million Medical Research Future Fund grant to commence a new DNA screening study that will identify cancer risk in young adults. The study will develop a low-cost test offered to 10,000 young Aussies with the aim to drastically improve access to preventative genetic testing. Associate Professor Paul Lacaze will work with a team of internationally recognised leaders to develop this tool and accelerate implementation into the healthcare system. | shorturl.at/kxAC5
Mental models help us understand the world. Management by Complexity is one such model. When you see it, you can combat it - and you can use the converse to get things done, better, at scale. https://partridgegp.me/telefarce
World
Microbiome Day (28 June 2021) encouraged people around the world to
explore all things microbial from the microorganisms in and on humans, animals,
water, plants, soil and food. Over half of the cells in the human body are
microbial in origin and the gut microbiome plays an important role in health.
The gut has become a source of great scientific research in the last
decade or so. Companies such as Australia's Microba Life Sciences are using
precise and comprehensive analysis of the gut microbiome to develop new
diagnostics and therapeutics to advance medicine globally. |
shorturl.at/jwABE
US-based biopharmaceutical company Qpex Biopharma Inc. have joined forces with Monash University researchers to drive clinical development of their APX9003 antibiotic. The researchers discovered this antibiotic to address an urgent unmet medical need to combat infections caused by antibiotic-resistant bacteria or superbugs. This new antibiotic has shown improved safety and efficacy over the currently used antibiotics. | https://www.monash.edu/news/articles/new-antibiotic-to-combat-deadly-bacterial-superbugs-enters-clinical-trials
A research team from Australia and the United States, comprised of leading universities, hospitals and industry, will embark on the world's first durable total artificial heart. The group - led by Monash University and BIVACOR, have received $1 million in Australia's Federal Government MRFF funding to develop and commercialise this new device through novel, innovative technology. They aim to take this technology to market within six years, saving lives, creating jobs and establishing Australia as world leaders in medical device development. | https://www.biospectrumasia.com/news/98/18388/australia-us-team-brings-world-first-durable-total-artificial-heart.html
